EdgarLookup

Chemomab Therapeutics Ltd. — Insider Transactions

Form 4 filings by directors, officers, and 10%+ shareholders

SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.

Overview All Filings Annual Quarterly Insiders
Insider Title Type Shares Price Value Owns After Date
OrbiMed Israel BioFund GP Limited Partnership Sale 266,376 $3.34 $889,696 2,311,798 Jan 3, 2023
Mor George Adi Chief Scientific Officer Sale 7,700 $5.03 $38,731 317,075 Jan 3, 2023
Cohen Neil Harris Sale 2,409 $2.00 $4,818 10,000 Nov 16, 2022
Mor George Adi Chief Scientific Officer Sale 257,248 $2.08 $535,076 257,247 Nov 16, 2022
Maryles Joel Michael Purchase 33 $2.76 $91 1,433 May 24, 2022
Cohen Neil Harris Purchase 2,000 $3.19 $6,380 12,409 May 18, 2022
Maryles Joel Michael Purchase 500 $4.32 $2,160 500 Mar 18, 2022
Marvin Donald Executive VP, CFO & COO Purchase 250 $3.25 $813 2,000 Mar 16, 2022
Marvin Donald Executive VP, CFO & COO Purchase 250 $3.98 $995 500 Mar 14, 2022
Pfost Dale R Chief Executive Officer Purchase 1,800 $3.98 $7,164 1,800 Mar 14, 2022
Cohen Neil Harris Purchase 2,000 $4.20 $8,400 6,409 Mar 14, 2022
Darvish Nissim Purchase 1,200 $4.28 $5,136 1,200 Mar 11, 2022
Cohen Neil Harris Purchase 2,000 $7.43 $14,860 4,409 Dec 6, 2021
Cohen Neil Harris Purchase 2,409 $41.51 $99,998 2,409 Mar 16, 2021
OrbiMed Israel GP Ltd. Award / Grant 288,170 $17.35 $4,999,750 2,578,174 Mar 16, 2021
THIEL PETER Purchase 230,536 1,108,509 Mar 16, 2021